Abstract:Background It is well established that both cerebral hypoperfusion/stroke and type 2 diabetes are risk factors for Alzheimer's disease (AD). Recently, the molecular link between ischemia/hypoxia and amyloid precursor protein (APP) processing has begun to be established. However, the role of the key common denominator, namely nitric oxide (NO), in AD is largely unknown. In this study, we investigated redox regulation of BACE1, the rate-limiting enzyme responsible for the β-cleavage of APP to Aβ peptides. Results Herein, we studied events such as S-nitrosylation, a covalent modification of cysteine residues by NO, and H 2 O 2 -mediated oxidation. We found that NO and H 2 O 2 differentially modulate BACE1 expression and enzymatic activity: NO at low concentrations (<100 nM) suppresses BACE1 transcription as well as its enzymatic activity while at higher levels (0.1-100 μM) NO induces S-nitrosylation of BACE1 which inactivates the enzyme without altering its expression. Moreover, the suppressive effect on BACE1 transcription is mediated by the NO/cGMP-PKG signaling, likely through activated PGC-1α. H 2 O 2 (1-10 μM) induces BACE1 expression via transcriptional activation, resulting in increased enzymatic activity. The differential effects of NO and H 2 O 2 on BACE1 expression and activity are also reflected in their opposing effects on Aβ generation in cultured neurons in a dose-dependent manner. Furthermore, we found that BACE1 is highly S-nitrosylated in normal aging brains while S-nitrosylation is markedly reduced in AD brains. Conclusion This study demonstrates for the first time that BACE1 is highly modified by NO via multiple mechanisms: low and high levels of NO suppress BACE1 via transcriptional and post translational regulation, in contrast with the upregulation of BACE1 by H 2 O 2 -mediated oxidation. These novel NO-mediated regulatory mechanisms likely protect BACE1 from being further oxidized by excessive oxidative stress, as from H 2 O 2 and peroxynitrite which are known to upregulate BACE1 and activate the enzyme, resulting in excessive cleavage of APP and Aβ generation; they likely represent the crucial house-keeping mechanism for BACE1 expression/activation under physiological conditions.

Effects of 4-Hydroxy-nonenal and Amyloid-Beta on Expression and Activity of Endothelin Converting Enzyme and Insulin Degrading Enzyme in Sh-Sy5y Cells

Effects of HNE‐modification Induced by Aβ on Neprilysin Expression and Activity in SH‐SY5Y Cells

The Effect of Chronic Cerebral Hypoperfusion on Amyloid-β Metabolism in a Transgenic Mouse Model of Alzheimer's Disease (PS1V97L).

Changes In Mitochondrial Dynamics During Amyloid Beta-Induced Pc12 Cell Apoptosis

Expression and Functional Profiling of Neprilysin, Insulin‐degrading Enzyme, and Endothelin‐converting Enzyme in Prospectively Studied Elderly and Alzheimer’s Brain

Endogenous Overproduction of Β-Amyloid Induces Tau Hyperphosphorylation and Decreases the Solubility of Tau in N2a Cells

Differential Regulation of BACE1 Expression by Oxidative and Nitrosative Signals

Beta amyloid effects on expression of multidrug efflux transporters in brain endothelial cells

Mitochondrial Respiratory Inhibition and Oxidative Stress Elevate Β-Secretase (BACE1) Proteins and Activity in Vivo in the Rat Retina

Role of Norepinephrine in Aβ-related Neurotoxicity: Dual Interactions with Tyr10 and SNK(26-28) of Aβ.

[Effects of Benzo(a)pyrene on Expressions of Insulin-Degrading Enzyme and Neprilysin in Neuroglia Cells].

Effect of Berberine Chloride on Expression of Insulin Degrading Enzyme in Rat Models with AD

Effects of Endogenous Β‐amyloid Overproduction on Tau Phosphorylation in Cell Culture

Amyloid beta accumulation in TgF344-AD rats is associated with reduced cerebral capillary endothelial Kir2.1 expression and neurovascular uncoupling

Exploration of the Molecular Mechanism for Lipoprotein Lipase Expression Variations in SH-SY5Y Cells Exposed to Different Doses of Amyloid-Beta Protein

Soluble Beta-Amyloid Peptides, but Not Insoluble Fibrils, Have Specific Effect on Neuronal MicroRNA Expression

Characteristics of Insulin-degrading Enzyme in Alzheimer's Disease: A Meta-Analysis.

The Effects Of Amyloid-Beta(42) Oligomer On The Proliferation And Activation Of Astrocytes In Vitro

Amyloid Beta–heme Peroxidase Promoted Protein Nitrotyrosination: Relevance to Widespread Protein Nitration in Alzheimer’s Disease

Murine Beta-Amyloid (1–42) Oligomers Disrupt Endothelial Barrier Integrity and VEGFR Signaling via Activating Astrocytes to Release Deleterious Soluble Factors

Cytotoxic role of advanced glycation end-products in PC12 cells treated with β‑amyloid peptide.